| Laura Dias Murray, LOTR | |
|
4908 Riverview Rd, Williamsburg, VA 23188-6719 | |
| (757) 525-1892 | |
| Not Available |
| Full Name | Laura Dias Murray |
|---|---|
| Gender | Female |
| Speciality | Contractor |
| Location | 4908 Riverview Rd, Williamsburg, Virginia |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1457563595 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 225X00000X | Occupational Therapist | 01190006010 (Virginia) | Secondary |
| 171W00000X | Contractor | Z11088 (Louisiana) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Laura Dias Murray, LOTR 4908 Riverview Rd, Williamsburg, VA 23188-6719 Ph: (757) 525-1892 | Laura Dias Murray, LOTR 4908 Riverview Rd, Williamsburg, VA 23188-6719 Ph: (757) 525-1892 |
News Archive
This year's IPF World Week (September 21-29) sees healthcare professionals, patient advocacy groups, people living with idiopathic pulmonary fibrosis (IPF), who have an estimated median survival time of two to five years, and their families calling for an integrated approach to further strengthen the national and international network of people working to support patients with this fatal orphan lung disease.
University of Southern California neuroscientists may have unlocked another puzzle to preventing risks that can lead to Alzheimer's disease. Researchers at Keck Medicine of USC used high-resolution imaging of the living human brain to show for the first time that the brain's protective blood barrier becomes leaky with age, starting at the hippocampus, a critical learning and memory center that is damaged by Alzheimer's disease.
Weeks ago, the tax bill under consideration in Congress became a health bill, too. But now it could also trigger major cuts to the Medicare program.
New hope is available for children who have a tumor called desmoid fibromatosis, according to results of a national clinical trial that was led by a St. Jude researcher.
› Verified 4 days ago